CVT 0.00% $1.22 comvita limited ordinary shares

Ann: KEYDATES: CVT: Comvita will announce half-year results on...

  1. lightbulb Created with Sketch. 2
    • Release Date: 05/11/15 08:57
    • Summary: KEYDATES: CVT: Comvita will announce half-year results on 10 November 2015
    • Price Sensitive: No
    • Download Document  2.41KB
    					CVT
    05/11/2015 08:57
    KEYDATES
    NOT PRICE SENSITIVE
    REL: 0857 HRS Comvita Limited
    
    KEYDATES: CVT: Comvita will announce half-year results on 10 November 2015
    
    On Tuesday 10 November, Comvita Limited (NZX:CVT) will release its results
    announcement for the half-year ended 30 September 2015.
    
    Chairman Neil Craig and CEO Scott Coulter will host a conference call for
    investors and media to discuss these results.
    
    Dial in details and the confirmation code are below.
    
    Date: Tuesday 10 November, 2015
    Time: 10:30am (NZST)
    Attendee dial in (New Zealand toll-free):   0800 450 585
    Confirmation code:   7868717
    
    International dial-in numbers for specific, toll-free country access:
    Australia:  1800 554 798
    China:  4001 935 569
    Hong Kong:  800 901 587
    South Korea:  00798 613 60978
    Taiwan:   00801 851 601
    Singapore:  800 6163 105
    Malaysia:  1800 812 876
    UK:   0808 234 8407
    USA:   1866 839 8029
    
    Confirmation code: 7868717
    
    # Ends #
    
    For further information:
    Scott Coulter, Comvita CEO, 021 386 988
    Neil Craig, Comvita Chairman, 021 731 509
    Julie Chadwick, Comvita Communications Manager, 021 510 693
    
    About Comvita (www.comvita.co.nz)
    Comvita (NZX:CVT) is a global natural health company committed to the
    development of innovative products, backed by ongoing investment in
    scientific research. We are the world leaders in Manuka (leptospermum) honey
    and fresh-picked Olive Leaf Extract, which are at the core of the Comvita
    product range.
    
    We have approximately 50% of honey supply under direct ownership or control,
    with the balance of supply from long term contractual and partnership
    arrangements. Comvita pioneered the development and use of medical grade
    Manuka honey and was the first to receive FDA approval (2007). We partner
    with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global
    licensee for Medihoney(R) specialist wound care products, which are used in
    hospitals and medical centres around the world. Comvita's freshly picked
    Olive Leaf Extract is grown, harvested, extracted and bottled at the world's
    largest specialised olive leaf grove, with over one million olive trees.
    
    Comvita sells into more than 18 countries through a network of our own
    branded retail locations, online (seven country specific e-commerce websites)
    and third-party outlets. We have over 500 staff located in New Zealand,
    Australia, Hong Kong, Japan, South Korea, the United Kingdom and the USA.
    End CA:00272877 For:CVT    Type:KEYDATES   Time:2015-11-05 08:57:10
    				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.